164 related articles for article (PubMed ID: 17937464)
1. Joint pain with aromatase inhibitors: abnormal frequency of Sjögren's syndrome.
Laroche M; Borg S; Lassoued S; De Lafontan B; Roché H
J Rheumatol; 2007 Nov; 34(11):2259-63. PubMed ID: 17937464
[TBL] [Abstract][Full Text] [Related]
2. Aromatase inhibitor-induced carpal tunnel syndrome: results from the ATAC trial.
Sestak I; Sapunar F; Cuzick J
J Clin Oncol; 2009 Oct; 27(30):4961-5. PubMed ID: 19752338
[TBL] [Abstract][Full Text] [Related]
3. Clinical and laboratory features of Sjögren's syndrome in young women with previous postpartum thyroiditis.
Gudbjörnsson B; Karlsson-Parra A; Karlsson E; Hällgren R; Kämpe O
J Rheumatol; 1994 Feb; 21(2):215-9. PubMed ID: 8182627
[TBL] [Abstract][Full Text] [Related]
4. Acute bilateral pulmonary emboli occurring while on adjuvant aromatase inhibitor therapy with anastrozole: Case report and review of the literature.
Lycette JL; Luoh SW; Beer TM; Deloughery TG
Breast Cancer Res Treat; 2006 Oct; 99(3):249-55. PubMed ID: 16752073
[TBL] [Abstract][Full Text] [Related]
5. Tolerance of adjuvant letrozole outside of clinical trials.
Fontaine C; Meulemans A; Huizing M; Collen C; Kaufman L; De Mey J; Bourgain C; Verfaillie G; Lamote J; Sacre R; Schallier D; Neyns B; Vermorken J; De Grève J
Breast; 2008 Aug; 17(4):376-81. PubMed ID: 18455395
[TBL] [Abstract][Full Text] [Related]
6. Choosing early adjuvant therapy for postmenopausal women with hormone-sensitive breast cancer: aromatase inhibitors versus tamoxifen.
Carpenter R
Eur J Surg Oncol; 2008 Jul; 34(7):746-55. PubMed ID: 18296017
[TBL] [Abstract][Full Text] [Related]
7. Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: ZO-FAST Study results.
Bundred NJ; Campbell ID; Davidson N; DeBoer RH; Eidtmann H; Monnier A; Neven P; von Minckwitz G; Miller JC; Schenk NL; Coleman RE
Cancer; 2008 Mar; 112(5):1001-10. PubMed ID: 18205185
[TBL] [Abstract][Full Text] [Related]
8. A case of aromatase inhibitor (anastrozole)-induced side-effects successfully treated with Kampo medicines.
Chino A; Okamoto H; Hirasaki Y; Ueda K; Ogawa K; Namiki T
J Altern Complement Med; 2011 Nov; 17(11):1075-7. PubMed ID: 22070441
[TBL] [Abstract][Full Text] [Related]
9. Aromatase inhibitor-induced arthralgia: clinical experience and treatment recommendations.
Coleman RE; Bolten WW; Lansdown M; Dale S; Jackisch C; Merkel D; Maass N; Hadji P
Cancer Treat Rev; 2008 May; 34(3):275-82. PubMed ID: 18082328
[TBL] [Abstract][Full Text] [Related]
10. Sjögren's syndrome and aromatase inhibitors treatment: is there a link?
Guidelli GM; Martellucci I; Galeazzi M; Francini G; Fioravanti A
Clin Exp Rheumatol; 2013; 31(4):653-4. PubMed ID: 23558055
[No Abstract] [Full Text] [Related]
11. Prospective study to assess short-term intra-articular and tenosynovial changes in the aromatase inhibitor-associated arthralgia syndrome.
Morales L; Pans S; Verschueren K; Van Calster B; Paridaens R; Westhovens R; Timmerman D; De Smet L; Vergote I; Christiaens MR; Neven P
J Clin Oncol; 2008 Jul; 26(19):3147-52. PubMed ID: 18474874
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus infection and primary Sjögren's syndrome: a clinical and serologic description of 9 patients.
Ceribelli A; Cavazzana I; Cattaneo R; Franceschini F
Autoimmun Rev; 2008 Dec; 8(2):92-4. PubMed ID: 18692602
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular adverse events during adjuvant endocrine therapy for early breast cancer using letrozole or tamoxifen: safety analysis of BIG 1-98 trial.
Mouridsen H; Keshaviah A; Coates AS; Rabaglio M; Castiglione-Gertsch M; Sun Z; Thürlimann B; Mauriac L; Forbes JF; Paridaens R; Gelber RD; Colleoni M; Smith I; Price KN; Goldhirsch A
J Clin Oncol; 2007 Dec; 25(36):5715-22. PubMed ID: 17998546
[TBL] [Abstract][Full Text] [Related]
14. Prospects of neoadjuvant aromatase inhibitor therapy in breast cancer.
Dixon JM
Expert Rev Anticancer Ther; 2008 Mar; 8(3):453-63. PubMed ID: 18366292
[TBL] [Abstract][Full Text] [Related]
15. Short-term and low-dose prednisolone administration reduces aromatase inhibitor-induced arthralgia in patients with breast cancer.
Kubo M; Onishi H; Kuroki S; Okido M; Shimada K; Yokohata K; Umeda S; Ogawa T; Tanaka M; Katano M
Anticancer Res; 2012 Jun; 32(6):2331-6. PubMed ID: 22641670
[TBL] [Abstract][Full Text] [Related]
16. Toxicity of aromatase inhibitors.
Pandya N; Morris GJ
Semin Oncol; 2006 Dec; 33(6):688-95. PubMed ID: 17145349
[TBL] [Abstract][Full Text] [Related]
17. Paucity of anti-hepatitis C virus antibodies in the serum of Indian patients with Sjogren's syndrome and inflammatory myositis.
Wanchu A; Chawla Y; Dhiman RK; Sud A; Bambery P
Indian J Pathol Microbiol; 2003 Apr; 46(2):191-3. PubMed ID: 15022906
[TBL] [Abstract][Full Text] [Related]
18. Understanding the BIG results: Insights from the BIG 1-98 trial analyses.
Wardley AM
Adv Ther; 2008 Dec; 25(12):1257-75. PubMed ID: 19096768
[TBL] [Abstract][Full Text] [Related]
19. Increased prevalence of antibodies to thyroid peroxidase in dry eyes and mouth syndrome or sicca asthenia polyalgia syndrome.
Mavragani CP; Skopouli FN; Moutsopoulos HM
J Rheumatol; 2009 Aug; 36(8):1626-30. PubMed ID: 19605678
[TBL] [Abstract][Full Text] [Related]
20. Beyond tamoxifen: extended and late extended endocrine therapy in postmenopausal early breast cancer.
Dodwell D; Williamson D
Cancer Treat Rev; 2008 Apr; 34(2):137-44. PubMed ID: 18006236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
